vs
Side-by-side financial comparison of G III APPAREL GROUP LTD (GIII) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $988.6M, roughly 1.4× G III APPAREL GROUP LTD). G III APPAREL GROUP LTD runs the higher net margin — 8.2% vs 1.4%, a 6.7% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -9.0%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-106.4M). Over the past eight quarters, G III APPAREL GROUP LTD's revenue compounded faster (13.7% CAGR vs 2.8%).
G III Apparel Group is a global fashion company that designs, sources, manufactures, markets and distributes apparel, footwear, and accessories under a range of owned and licensed well-known brands. It serves department stores, specialty retailers, and e-commerce platforms across North America, Europe, and other key global markets, catering to casual, sportswear, and premium fashion consumer segments.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
GIII vs SEM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $988.6M | $1.4B |
| Net Profit | $80.6M | $20.2M |
| Gross Margin | 38.6% | — |
| Operating Margin | 11.4% | 4.6% |
| Net Margin | 8.2% | 1.4% |
| Revenue YoY | -9.0% | 6.4% |
| Net Profit YoY | -29.8% | 225.7% |
| EPS (diluted) | $1.84 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $988.6M | $1.4B | ||
| Q3 25 | $613.3M | $1.4B | ||
| Q2 25 | $583.6M | $1.3B | ||
| Q1 25 | $839.5M | $1.4B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $644.8M | $1.3B | ||
| Q2 24 | $609.7M | $1.3B | ||
| Q1 24 | $764.8M | $1.3B |
| Q4 25 | $80.6M | $20.2M | ||
| Q3 25 | $10.9M | $28.8M | ||
| Q2 25 | $7.8M | $40.6M | ||
| Q1 25 | $48.8M | $56.7M | ||
| Q4 24 | $114.8M | $-16.1M | ||
| Q3 24 | $24.2M | $55.6M | ||
| Q2 24 | $5.8M | $77.6M | ||
| Q1 24 | $28.9M | $96.9M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 40.8% | — | ||
| Q2 25 | 42.2% | — | ||
| Q1 25 | 39.5% | — | ||
| Q4 24 | 39.8% | — | ||
| Q3 24 | 42.8% | — | ||
| Q2 24 | 42.5% | — | ||
| Q1 24 | 36.9% | — |
| Q4 25 | 11.4% | 4.6% | ||
| Q3 25 | 2.7% | 5.4% | ||
| Q2 25 | 1.5% | 6.5% | ||
| Q1 25 | 8.5% | 8.3% | ||
| Q4 24 | 15.3% | 1.6% | ||
| Q3 24 | 6.4% | 4.3% | ||
| Q2 24 | 2.2% | 5.8% | ||
| Q1 24 | 6.1% | 9.0% |
| Q4 25 | 8.2% | 1.4% | ||
| Q3 25 | 1.8% | 2.1% | ||
| Q2 25 | 1.3% | 3.0% | ||
| Q1 25 | 5.8% | 4.2% | ||
| Q4 24 | 10.6% | -1.2% | ||
| Q3 24 | 3.8% | 4.4% | ||
| Q2 24 | 1.0% | 6.1% | ||
| Q1 24 | 3.8% | 7.3% |
| Q4 25 | $1.84 | $0.17 | ||
| Q3 25 | $0.25 | $0.23 | ||
| Q2 25 | $0.17 | $0.32 | ||
| Q1 25 | $1.00 | $0.44 | ||
| Q4 24 | $2.55 | $-0.12 | ||
| Q3 24 | $0.53 | $0.43 | ||
| Q2 24 | $0.12 | $0.60 | ||
| Q1 24 | $0.59 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.1M | $26.5M |
| Total DebtLower is stronger | $6.5M | $1.8B |
| Stockholders' EquityBook value | $1.8B | $1.7B |
| Total Assets | $2.8B | $5.9B |
| Debt / EquityLower = less leverage | 0.00× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $184.1M | $26.5M | ||
| Q3 25 | $301.8M | $60.1M | ||
| Q2 25 | $257.8M | $52.3M | ||
| Q1 25 | $181.4M | $53.2M | ||
| Q4 24 | $104.7M | $59.7M | ||
| Q3 24 | $414.8M | $191.5M | ||
| Q2 24 | $508.4M | $111.2M | ||
| Q1 24 | $507.8M | $92.6M |
| Q4 25 | $6.5M | $1.8B | ||
| Q3 25 | $6.9M | $1.7B | ||
| Q2 25 | $6.8M | $1.8B | ||
| Q1 25 | $3.0M | $1.8B | ||
| Q4 24 | $213.9M | $1.7B | ||
| Q3 24 | $402.5M | $3.1B | ||
| Q2 24 | $402.7M | $3.6B | ||
| Q1 24 | $402.8M | $3.8B |
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.7B | $1.7B | ||
| Q1 25 | $1.7B | $1.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.9B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $2.8B | $5.9B | ||
| Q3 25 | $2.7B | $5.7B | ||
| Q2 25 | $2.4B | $5.7B | ||
| Q1 25 | $2.5B | $5.7B | ||
| Q4 24 | $2.8B | $5.6B | ||
| Q3 24 | $2.7B | $8.0B | ||
| Q2 24 | $2.6B | $7.9B | ||
| Q1 24 | $2.7B | $7.9B |
| Q4 25 | 0.00× | 1.06× | ||
| Q3 25 | 0.00× | 1.03× | ||
| Q2 25 | 0.00× | 1.10× | ||
| Q1 25 | 0.00× | 1.03× | ||
| Q4 24 | 0.13× | 1.01× | ||
| Q3 24 | 0.27× | 1.62× | ||
| Q2 24 | 0.26× | 2.54× | ||
| Q1 24 | 0.26× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-97.3M | $64.3M |
| Free Cash FlowOCF − Capex | $-106.4M | $5.2M |
| FCF MarginFCF / Revenue | -10.8% | 0.4% |
| Capex IntensityCapex / Revenue | 0.9% | 4.2% |
| Cash ConversionOCF / Net Profit | -1.21× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $367.7M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-97.3M | $64.3M | ||
| Q3 25 | $75.1M | $175.3M | ||
| Q2 25 | $93.8M | $110.3M | ||
| Q1 25 | $333.4M | $-3.5M | ||
| Q4 24 | $-111.8M | $125.4M | ||
| Q3 24 | $49.3M | $181.0M | ||
| Q2 24 | $45.5M | $278.2M | ||
| Q1 24 | $361.3M | $-66.7M |
| Q4 25 | $-106.4M | $5.2M | ||
| Q3 25 | $64.7M | $122.2M | ||
| Q2 25 | $85.7M | $45.6M | ||
| Q1 25 | $323.7M | $-55.8M | ||
| Q4 24 | $-120.3M | $62.0M | ||
| Q3 24 | $38.8M | $130.3M | ||
| Q2 24 | $32.8M | $222.6M | ||
| Q1 24 | $352.3M | $-119.2M |
| Q4 25 | -10.8% | 0.4% | ||
| Q3 25 | 10.6% | 9.0% | ||
| Q2 25 | 14.7% | 3.4% | ||
| Q1 25 | 38.6% | -4.1% | ||
| Q4 24 | -11.1% | 4.7% | ||
| Q3 24 | 6.0% | 10.2% | ||
| Q2 24 | 5.4% | 17.4% | ||
| Q1 24 | 46.1% | -9.0% |
| Q4 25 | 0.9% | 4.2% | ||
| Q3 25 | 1.7% | 3.9% | ||
| Q2 25 | 1.4% | 4.8% | ||
| Q1 25 | 1.2% | 3.9% | ||
| Q4 24 | 0.8% | 4.8% | ||
| Q3 24 | 1.6% | 4.0% | ||
| Q2 24 | 2.1% | 4.3% | ||
| Q1 24 | 1.2% | 4.0% |
| Q4 25 | -1.21× | 3.19× | ||
| Q3 25 | 6.86× | 6.09× | ||
| Q2 25 | 12.09× | 2.72× | ||
| Q1 25 | 6.83× | -0.06× | ||
| Q4 24 | -0.97× | — | ||
| Q3 24 | 2.04× | 3.25× | ||
| Q2 24 | 7.84× | 3.59× | ||
| Q1 24 | 12.52× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
